Elixinol refocuses CBD strategy, global ambitions amid FDA inaction

Australian hemp company Elixinol Global had grand ambitions when it went public on the Australian Securities Exchange in January 2018, offering what might be termed the holy trinity of hemp business offerings: one for hemp and CBD supplements, one for hemp food products and one for an emerging medicinal marijuana market in Australia. Less than […]

Elixinol refocuses CBD strategy, global ambitions amid FDA inaction is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs